Tratamiento de la depresión

  1. Álvarez de Mon González, Miguel Ángel 1
  2. Pereira, V. 1
  3. Ortuño, F. 1
  1. 1 Clínica Universitaria de Navarra
    info

    Clínica Universitaria de Navarra

    Pamplona, España

    ROR https://ror.org/03phm3r45

Revue:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Année de publication: 2017

Titre de la publication: Actualidad clínico-terapéutica (II)

Serie: 12

Número: 46

Pages: 2731-2742

Type: Article

DOI: 10.1016/J.MED.2017.12.001 DIALNET GOOGLE SCHOLAR

D'autres publications dans: Medicine: Programa de Formación Médica Continuada Acreditado

Résumé

Resumen Introducción El trastorno depresivo mayor es el principal de los trastornos depresivos recogidos en el DSM-5. Afecta a poblaciones de cualquier edad y sexo, y se manifiesta con síntomas cognitivos, conductuales y afectivos. El riesgo suicida es elevado. Tratamientos farmacológicos Existen numerosos fármacos eficaces en los trastornos depresivos que se clasifican según su mecanismo de acción. Destacan los inhibidores selectivos de la recaptación de la serotonina (ISRS) por su eficacia y seguridad. Tratamientos no farmacológicos Entre los tratamientos de neuromodulación, la terapia electroconvulsiva (TEC) es una alternativa eficaz en casos resistentes al tratamiento farmacológico. Por otra parte, cambios en el estilo de vida y algunas intervenciones psicoterapéuticas pueden resultar de utilidad en muchos pacientes. Protocolo de tratamiento Los ISRS son la primera línea en la depresión mayor, pudiendo utilizarse otros fármacos como sustitutos o coadyuvantes en líneas posteriores de tratamiento. La TEC debe considerarse en depresión resistente en adultos y en mujeres embarazadas.

€ Voir financement

Information sur le financement

32 1 2012 114 119 26 National Collaborating Centre for Mental Health. Depression in children and young people: identification and management in primary, community and secondary care (NICE guideline CG28). Leicester and London (UK): British Psychological Society and The Royal College of Psychiatrists; 2005. 27 Grupo de Trabajo de la Guía de Práctica Clínica sobre la Depresión Mayor en la Infancia y en la Adolescencia. Guía de Práctica Clínica sobre la Depresión Mayor en la Infancia y en la Adolescencia. Plan de Calidad para el Sistema Nacional de Salud del Ministerio de Sanidad y Política Social. Axencia de Avaliación de Tecnoloxías Sanitarias de Galicia (avalia-t); 2009. 28 C. Soutullo

Financeurs

Références bibliographiques

  • Kessler RC, Bromet EJ. The epidemiology of depression across cultures. Annu Rev Public Health. 2013;34:119-38.
  • Polanczyk GV, Salum GA, Sugaya LS, Caye A, Rohde LA. Annual re-search review: A meta-analysis of the worldwide prevalence of mental disorders in children and adolescents. J Child Psychol Psychiatry. 2015;56(3):345-65.
  • Nock MK, Borges G, Bromet EJ, Cha CB, Kessler RC, Lee S. Suicide and suicidal behavior. Epidemiol Rev. 2008;30:133-54.
  • American Psychiatric Association.. Manual diagnóstico y estadístico de los trastornos mentales. 5ª ed. Buenos Aires: Editorial Médica Panamericana; 2014.
  • Dean J, Keshavan M. The neurobiology of depression: an integrated view. Asian J Psychiatr. 2017;27:101-11
  • Powers MB, de Kleine RA, Smits JAJ. Core mechanisms of cognitive behavioral therapy for anxiety and depression: a review. Psychiatr Clin North Am. 2017;40(4):611-23.
  • Liu B, Liu J, Wang M, Zhang Y, Li L. From serotonin to neuroplasticity: evolvement of theories for major depressive disorder. Front Cell Neurosci. 2017;11:305.
  • Hillhouse TM, Porter JH. A brief history of the development of antide-pressant drugs: from monoamines to glutamate. Exp Clin Psychopharmacol. 2015;23(1):1-21.
  • Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R. Comparative efficacy and acceptability of 12 new generation antidepressants: a multiple treatments meta-analysis. Lancet. 2009;373(9665):746-58.
  • Cipriani A, Zhou X, Del Giovane C, Hetrick SE, Qin B, Whittington C. Comparative efficacy and tolerability of antidepres sants for major depressive disorder in children and adolescents: a network meta-analysis. Lancet. 2016; 388(10047):881-90.
  • Stahl SM. Psicofarmacología esencial de Stahl. Madrid: Aula Médica; 2013.
  • Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev. 2013;(5):CD009329.
  • Solas M, Milagro FI, Martínez-Urbistondo D, Ramírez MJ, Martínez JA. Precision obesity treatments including pharmacogenetic and nutrigenetic approaches. Trends Pharmacol Sci. 2016;37(7):575-93.
  • Sienaert P. Mechanisms of ECT: Reviewing the science and dis-missing the myths. J ECT. 2014;30:85-6.
  • Fink M. Celebrating 80 years of inducing brain seizures as psychiatric treatment. J ECT. 2014;30:90.
  • Husain MM, Rush AJ, Fink M, Knapp R, Petrides G, Rummans T. Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): A consortium for research in ECT (CORE) report. J Clin Psychiatry. 2004;65:485-91.
  • Berlim MT, van den Eynde F, Tovar-Perdomo S, Daskalakis ZJ. Response, remission and drop out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham controlled trials. Psychol Med. 2014;44(2):225-39.
  • Chen JJ, Zhao LB, Liu YY, Fan SH, Xie P. Comparative efficacy and acceptability of electroconvulsive therapy versus repetitive transcranial magnetic stimulation for major depression: A systematic review and multiple treatments meta-analysis. Behav Brain Res. 2017;320:30-6.
  • Cimpianu CL, Strube W, Falkai P, Palm U, Hasan A. Vagus nerve stimulation in psychiatry: a systematic review of the available evidence. J Neural Transm (Vienna). 2017;124(1):145-58.
  • Morishita T, Fayad SM, Higuchi MA, Nestor KA, Foote KD. Deep brain stimulation for treatment-resistant depression: systematic review of clinical outcomes. Neurotherapeutics. 2014;11(3):475-84.
  • Molero P, Martínez-González MA, Ruiz-Canela M, Lahortiga F, Sánchez-Villegas A, Pérez-Cornago A. Cardiovascular risk and incidence of depression in young and older adults: evidence from the SUN cohort study. World Psychiatry. 2017;16(1):111.
  • Lemmens LH, Arntz A, Peeters F, Hollon SD, Roefs A, Huibers MJ. Clinical effectiveness of cognitive therapy v. interpersonal psychotherapy for depression: results of a randomized controlled trial. Psychol Med. 2015;45(10):2095-110.
  • Kennedy SH, Lam RW, McIntyre RS, Tourjman SV, Bhat V, Blier P. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments. Can J Psychiatry. 2016; 61(9):540-60.
  • Taylor D, Paton C, Kapur S. The Maudsley prescribing guidelines in psychiatry. 12th ed. West Sussex: Wiley Blackwell; 2015.
  • Gaynes BN, Dusetzina SB, Ellis AR, Hansen RA, Farley JF, Miller WC. Treating depression after initial treatment failure: directly comparing switch and augmenting strategies in STARD. J Clin Psychopharmacol. 2012;32(1):114-9.
  • Soutullo C, editor. Guía esencial de psicofarmacología del niño y el adolescente. Madrid: Editorial Médica Panamericana S.A.; 2016.
  • Locher C, Koechlin H, Zion SR, Werner C, Pine DS, Kirsch I. Efficacy and safety of selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, and placebo for common psychiatric disorders among children and adolescents: a systematic review and meta-analysis. JAMA Psychiatry. 2017;74(10): 1011-20.
  • Goldsmith M, Singh M, Chang K. Antidepressants and psychostimulants in pediatric populations: is there an association with mania? Paediatr Drugs. 2011;13(4):225-43.
  • Jarde A, Morais M, Kingston D, Giallo R, MacQueen GM, Giglia L. Neonatal outcomes in women with untreated antenatal depression compared with women without depression: A systematic review and meta-analysis. JAMA Psychiatry. 2016;73(8):826-37.
  • Ornoy A, Koren G. Selective serotonin reuptake Inhibitors during preg-nancy: do we have now more definite answers related to prenatal exposure? Birth Defects Res. 2017;109(12):898-908.
  • National Collaborating Centre for Mental Health. Antenatal and postnatal mental health: clinical management and service guidance (CG192). 2014. Leicester and London (UK): British Psychological Society and The Royal College of Psychiatrists; 2014.
  • Berle JO, Spigset O. Antidepressant Use during breastfeeding. Curr Womens Health Rev. 2011;7(1):28-34.
  • Kok RM, Reynolds III CF. Management of depression in older adults. A review. JAMA. 2017;317(20):2114-22.
La source de données: Dialnet